EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France

BACKGROUND EQOFIX is a medicoeconomic study that analyzed the health‐related quality of life (HRQoL) and costs of care of the moderate and severe forms of hemophilia B, treated on demand or by prophylaxis with either plasma‐derived Factor IX (pdFIX) or recombinant FIX (rFIX). STUDY DESIGN AND METHOD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transfusion Jg. 55; H. 7; S. 1787 - 1797
Hauptverfasser:	Polack, Benoît, Calvez, Thierry, Chambost, Hervé, Rothschild, Chantal, Goudemand, Jenny, Claeyssens, Ségolène, Borel-Derlon, Annie, Bardoulat, Isabelle, Maurel, Frédérique, Woronoff-Lemsi, Marie-Christine
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Blackwell Publishing Ltd 01.07.2015 Wiley Wiley Subscription Services, Inc
Schlagworte:	[INFO.INFO-BT]Computer Science [cs]/Biotechnology Adolescent Adult Child Cohort Studies Costs Costs and Cost Analysis Economics and Finance Factor IX Factor IX - administration & dosage Factor IX - economics Female France Hematology Hemophilia Hemophilia B Hemophilia B - drug therapy Hemophilia B - economics Hemorrhage Hemorrhage - economics Hemorrhage - prevention & control Human health and pathology Humanities and Social Sciences Humans Life Sciences Male Middle Aged Quality of Life Santé publique et épidémiologie France
ISSN:	0041-1132, 1537-2995, 1537-2995
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!